DK1137420T3 - Anvendelse af en kombination af et purin og en nitrogenmonooxiddonor til forebyggelse eller behandling af sexuel dysfunktion - Google Patents

Anvendelse af en kombination af et purin og en nitrogenmonooxiddonor til forebyggelse eller behandling af sexuel dysfunktion

Info

Publication number
DK1137420T3
DK1137420T3 DK99958233T DK99958233T DK1137420T3 DK 1137420 T3 DK1137420 T3 DK 1137420T3 DK 99958233 T DK99958233 T DK 99958233T DK 99958233 T DK99958233 T DK 99958233T DK 1137420 T3 DK1137420 T3 DK 1137420T3
Authority
DK
Denmark
Prior art keywords
purine
combination
prevention
treatment
sexual dysfunction
Prior art date
Application number
DK99958233T
Other languages
Danish (da)
English (en)
Inventor
Philippe Gorny
Original Assignee
Adenobio N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adenobio N V filed Critical Adenobio N V
Application granted granted Critical
Publication of DK1137420T3 publication Critical patent/DK1137420T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK99958233T 1998-12-02 1999-12-02 Anvendelse af en kombination af et purin og en nitrogenmonooxiddonor til forebyggelse eller behandling af sexuel dysfunktion DK1137420T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9815237A FR2786699B1 (fr) 1998-12-02 1998-12-02 Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles
PCT/FR1999/002993 WO2000032202A1 (fr) 1998-12-02 1999-12-02 Obtention et utilisation d'une combinaison d'une purine et d'un agent donneur de monoxyde d'azote pour prevenir ou traiter les dysfonctions sexuelles

Publications (1)

Publication Number Publication Date
DK1137420T3 true DK1137420T3 (da) 2007-08-06

Family

ID=9533506

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99958233T DK1137420T3 (da) 1998-12-02 1999-12-02 Anvendelse af en kombination af et purin og en nitrogenmonooxiddonor til forebyggelse eller behandling af sexuel dysfunktion

Country Status (12)

Country Link
US (2) US6506736B1 (de)
EP (1) EP1137420B1 (de)
JP (1) JP2002531408A (de)
AT (1) ATE358490T1 (de)
AU (1) AU1564500A (de)
CY (1) CY1106702T1 (de)
DE (1) DE69935733T2 (de)
DK (1) DK1137420T3 (de)
ES (1) ES2285865T3 (de)
FR (1) FR2786699B1 (de)
PT (1) PT1137420E (de)
WO (1) WO2000032202A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786699B1 (fr) * 1998-12-02 2002-10-04 Philippe Gorny Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles
WO2007075151A1 (en) * 2005-12-29 2007-07-05 Victor Pavlovich Kutnyak Composite vasodilator based on a no-group donator and a promoter
FR3005262A1 (fr) 2013-05-02 2014-11-07 Philippe Gorny Nouvelles compositions pharmaceutiques ou dietetiques permettant de masquer totalement l'amertume des sels d'arginine donnes a haute dose, sous forme liquide ou semi-liquide.
FR3012039A1 (fr) * 2013-10-22 2015-04-24 Philippe Olivier Gorny Medicament ou produit dietetique et son utilisation pour prevenir ou traiter les dysfonctionnements sexuels de l'homme et de la femme

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63179827A (ja) * 1987-01-20 1988-07-23 Fuso Yakuhin Kogyo Kk アデノシン三リン酸とマグネシウムイオンを含む安定な製剤
DE4117249C2 (de) * 1991-05-27 1998-05-14 Christian Dr Stief Linsidomin zur Behandlung erektiler Dysfunktionen
RU2064792C1 (ru) * 1992-03-02 1996-08-10 Свистов Александр Сергеевич Антиангинальное жидкое средство для трансдермального применения
GB2268871A (en) * 1992-07-04 1994-01-26 Bio Nutritional Health Service Composition for use as a food or food supplement
DK100392D0 (da) * 1992-08-10 1992-08-10 Gea Farmaceutisk Fabrik As 3- og 5-substituerede 1,2,3,4-oxatriazol-5-iminforbindelser og fremgangsmaade til fremstilling deraf, farmaceutisk praeparat indeholdende disse forbindelser samt forbindelsernes anvendelse til fremstilling af laegemidler
BR9203277A (pt) * 1992-08-21 1994-03-01 Cesar Roberto Dias Nahoum Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao
US5910316A (en) * 1992-08-24 1999-06-08 The United States Of America, As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents to treat impotency
US5422343A (en) * 1992-12-21 1995-06-06 Otsuka Pharmaceutical Factory, Inc. Prophylactic and therapeutic composition for MRSA infection
US5594032A (en) * 1994-11-10 1997-01-14 Gonzalez-Cadavid; Nestor F. Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA
US5612060A (en) * 1995-05-25 1997-03-18 Alexander; J. Wesley Enhancement of transplant graft survival through nutritional immunomodulation and immunosuppressive therapy
JP4526047B2 (ja) * 1995-11-08 2010-08-18 雪印乳業株式会社 体力増強剤
US5824669A (en) * 1996-03-22 1998-10-20 Nitromed, Inc. Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
GB9608408D0 (en) * 1996-04-23 1996-06-26 Adams Michael A Treatment of erectile dysfunction
US5877216A (en) * 1997-10-28 1999-03-02 Vivus, Incorporated Treatment of female sexual dysfunction
US6127363A (en) * 1997-10-28 2000-10-03 Vivus, Inc. Local administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunction
US6124461A (en) * 1998-05-26 2000-09-26 Saint Louis University, Health Services Center, Research Administration Compounds, compositions, and methods for treating erectile dysfunction
WO2000000212A1 (en) * 1998-06-26 2000-01-06 Nutracorp Scientific, Inc. Promoting nitric oxide and cyclic gmp activity
US6007824A (en) * 1998-07-09 1999-12-28 Duckett; Melvin J. Natural composition and method for the treatment of sexual dysfunction
FR2786699B1 (fr) * 1998-12-02 2002-10-04 Philippe Gorny Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles

Also Published As

Publication number Publication date
JP2002531408A (ja) 2002-09-24
CY1106702T1 (el) 2012-05-23
PT1137420E (pt) 2007-07-04
DE69935733D1 (de) 2007-05-16
FR2786699B1 (fr) 2002-10-04
DE69935733T2 (de) 2007-12-27
ATE358490T1 (de) 2007-04-15
US20030195165A1 (en) 2003-10-16
ES2285865T3 (es) 2007-11-16
EP1137420B1 (de) 2007-04-04
FR2786699A1 (fr) 2000-06-09
AU1564500A (en) 2000-06-19
EP1137420A1 (de) 2001-10-04
US6506736B1 (en) 2003-01-14
WO2000032202A1 (fr) 2000-06-08

Similar Documents

Publication Publication Date Title
DE69733968D1 (de) Norbornen- und norbornandiolen zur behandlung von pigmentierungsstörungen, neurodegenerativen erkrankungen oder proliferativen hauterkrankungen
BR9711447A (pt) Uso de glp-1 an logos no tratamento de enfarte de mioc rdio
ES543862A0 (es) Procedimiento para apreciar variaciones en el tiempo de caracteristicas somaticas de personas sometidas a tratamiento deadelgazamiento, cicatrizacion y otros.
ATE302003T1 (de) Zubereitungen enthaltend apomorphin und sildenafil und ihre verwendung zur behandlung von erektiler dysfunktion
ATE332136T1 (de) Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten
EP0211354A3 (de) Nukleoside und ihre Verwendung als antineoplastische Wirkstoffe
DK164441C (da) Anvendelse af et piperidinderivat til fremstilling af et farmaceutisk praeparat til behandling af smertetilstande
DK0841939T3 (da) Terapeutiske midler og autoimmune sygdomme
NO894222D0 (no) Fremgangsmaater for behandling av profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer til anvendelse i nevnte metoder.
IL138290A0 (en) Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
WO2004007676A3 (en) Combination therapy for the treatment of neoplasms
DK1137420T3 (da) Anvendelse af en kombination af et purin og en nitrogenmonooxiddonor til forebyggelse eller behandling af sexuel dysfunktion
TR200102512T2 (tr) Tüm ruhsal bozukluklar, adaptasyon bozuklukları ve çeşitli kaygı-depresyon bozukluklarının tedavisinde ya da önlenmesinde yararlı tıbbi ürünlerin hazırlanması için saredutan ve onun farmasötik olarak kabul edilebilir tuzlarının kullanımı.
WO1999056666A8 (en) The treatment of sexual dysfunction in certain patient groups
AR015956A1 (es) Composiciones de citoquinas oromucosales y usos de las mismas
ES2185310T3 (es) Agente antivirico herbario.
ES2042818T3 (es) Agente terapeutico para la trombocitopenia.
HUP9900945A2 (hu) Nukleozidanalógok herpes simplex vírus fertőzések kombinációs terápiájában
DK1049461T3 (da) Anvendelse af topiske præparater af glyceryltrinitrat og lanolin til behandling af erektil dysfunktion
RU93050675A (ru) Способ коррекции психофизиологического состояния человека
DK1007085T3 (da) Anvendelse af væksthormon i præparater til behandling af insulin-resistens i hjertet
JPS6485990A (en) Antihypertestoeronemia agent
NO960866D0 (no) Fremgangsmåte til behandling av leversykdom og lignende indikasjoner med vasodilaterende midler
DK1328273T3 (da) Anordning og fremgangsmåder til transdermal indgivelse af felodipin
葛通远 et al. AN APPROACH TO THE MECHANISMS OF LASER ACUPUNCTURE IN TREATMENT OF EXOPHTHALMIC HYPERTHYROIDISM